@article{krumholz_what_2007,
	title = {What have we learnt from {Vioxx}?},
	volume = {334},
	copyright = {© BMJ Publishing Group Ltd 2007},
	issn = {0959-8138, 1468-5833},
	url = {https://www.bmj.com/content/334/7585/120},
	doi = {10.1136/bmj.39024.487720.68},
	abstract = {In October UK patients who had cardiovascular events while taking rofecoxib lost the right to fight Merck in the US for compensation. But researchers and journals can still benefit from this case if they learn from the mistakes, write Harlan Krumholz and colleagues},
	language = {en},
	number = {7585},
	urldate = {2019-10-04},
	journal = {BMJ},
	author = {Krumholz, Harlan M. and Ross, Joseph S. and Presler, Amos H. and Egilman, David S.},
	month = jan,
	year = {2007},
	pmid = {17235089},
	keywords = {8 Ignorance and funding bias},
	pages = {120--123},
}

{"_id":"LQavBqcpz5Hn4ry2s","bibbaseid":"krumholz-ross-presler-egilman-whathavewelearntfromvioxx-2007","authorIDs":[],"author_short":["Krumholz, H. M.","Ross, J. S.","Presler, A. H.","Egilman, D. S."],"bibdata":{"bibtype":"article","type":"article","title":"What have we learnt from Vioxx?","volume":"334","copyright":"© BMJ Publishing Group Ltd 2007","issn":"0959-8138, 1468-5833","url":"https://www.bmj.com/content/334/7585/120","doi":"10.1136/bmj.39024.487720.68","abstract":"In October UK patients who had cardiovascular events while taking rofecoxib lost the right to fight Merck in the US for compensation. But researchers and journals can still benefit from this case if they learn from the mistakes, write Harlan Krumholz and colleagues","language":"en","number":"7585","urldate":"2019-10-04","journal":"BMJ","author":[{"propositions":[],"lastnames":["Krumholz"],"firstnames":["Harlan","M."],"suffixes":[]},{"propositions":[],"lastnames":["Ross"],"firstnames":["Joseph","S."],"suffixes":[]},{"propositions":[],"lastnames":["Presler"],"firstnames":["Amos","H."],"suffixes":[]},{"propositions":[],"lastnames":["Egilman"],"firstnames":["David","S."],"suffixes":[]}],"month":"January","year":"2007","pmid":"17235089","keywords":"8 Ignorance and funding bias","pages":"120–123","bibtex":"@article{krumholz_what_2007,\n\ttitle = {What have we learnt from {Vioxx}?},\n\tvolume = {334},\n\tcopyright = {© BMJ Publishing Group Ltd 2007},\n\tissn = {0959-8138, 1468-5833},\n\turl = {https://www.bmj.com/content/334/7585/120},\n\tdoi = {10.1136/bmj.39024.487720.68},\n\tabstract = {In October UK patients who had cardiovascular events while taking rofecoxib lost the right to fight Merck in the US for compensation. But researchers and journals can still benefit from this case if they learn from the mistakes, write Harlan Krumholz and colleagues},\n\tlanguage = {en},\n\tnumber = {7585},\n\turldate = {2019-10-04},\n\tjournal = {BMJ},\n\tauthor = {Krumholz, Harlan M. and Ross, Joseph S. and Presler, Amos H. and Egilman, David S.},\n\tmonth = jan,\n\tyear = {2007},\n\tpmid = {17235089},\n\tkeywords = {8 Ignorance and funding bias},\n\tpages = {120--123},\n}\n\n\n\n","author_short":["Krumholz, H. M.","Ross, J. S.","Presler, A. H.","Egilman, D. S."],"key":"krumholz_what_2007","id":"krumholz_what_2007","bibbaseid":"krumholz-ross-presler-egilman-whathavewelearntfromvioxx-2007","role":"author","urls":{"Paper":"https://www.bmj.com/content/334/7585/120"},"keyword":["8 Ignorance and funding bias"],"metadata":{"authorlinks":{}},"downloads":0},"bibtype":"article","biburl":"http://bibbase.org/zotero-group/science_et_ignorance/1340424","creationDate":"2019-12-03T14:38:49.053Z","downloads":0,"keywords":["8 ignorance and funding bias"],"search_terms":["learnt","vioxx","krumholz","ross","presler","egilman"],"title":"What have we learnt from Vioxx?","year":2007,"dataSources":["zX4acseCDM6D58AW7","NTvuMntpta5z9CAbT","5XkfmA9xajmKjWGio"]}